FP7 to strengthen support for pan-European research infrastructures

EU Science and Research Commissioner Janez Potocnik has provided details of how the Seventh Framework Programme (FP7) will continue to support the development of integrated research infrastructures of pan European interest.

Speaking to an audience at the German Science Council in Mainz on 7 July, Mr Potocnik said that researchers were increasingly finding it difficult to complete their research projects within the confines of their own laboratories.

"In many cases, for the most ambitious projects, they need to rely upon the services of a larger research facility. Accessing research facilities in a foreign country has in the past often been associated with more or less administrative and financial burden," he said.

Reacting to this situation, the European Commission has developed a number of initiatives within the Framework Programme (FP) to help researchers overcome these difficulties. They include the financing of 'Transnational Access', which fund access to major research infrastructures actions for research teams. This will continue under FP7, assured the Commissioner.

With the start of Sixth Framework Programme (FP6), the Commission went even further, noted Mr Potocnik, introducing 'Integrated Infrastructure Initiatives', through which Research Infrastructures (RIs) can coordinate their services and their development to fit better the needs of the scientific community. This programme combines, within a single contract, networking activities (including consortium management); provision of access to transnational users; and joint research activities.

Key to the development of RIs is the work undertaken by the European Strategy Forum for Research Infrastructures (ESFRI). Established in 2002, the Forum brings together representatives of EU Member States and Associated States, as well as the Commission, to support a coherent approach to policy-making on research infrastructures in Europe, and to act as an incubator for international negotiations on concrete initiatives.

Together with the Commission, ESFRI is set to produce the first roadmap for new infrastructures. To be launched in the autumn, the roadmap will identify new infrastructures of pan-European interest (or major upgrades) corresponding to needs of the European research communities, covering all scientific areas, regardless of possible location.

"It will therefore be a useful tool for every policy maker in Europe in offering numerous options for research investment," said the Commissioner.

In a recent review of its national research projects, the German Science Council concluded that several projects were of such a dimension and scientific aspiration that they would be better pursued jointly at international level. These included the Facility for Antiproton and Ion Research (FAIR) and the X-Ray Free Electron Laser (XFEL). Furthermore, The Council also recommended that research vessel Aurora Borealis be realised as a joint European effort.

"This makes these project natural candidates for the European Roadmap. The Commission intends to use the ESFRI list of projects for focusing its support activities for new construction projects under FP7," said Mr Potocnik.

He went on to note that in FP7, the Commission will expand its support to international consortia, which will eventually result in facilities built on a joint basis. "The Commission has indeed the capability to play a catalysing role in the negotiations for intergovernmental agreements," said the Commissioner.

Regarding construction of such facilities, Mr Potocnik suggested that Community support could take the form of sharing some of the construction costs, as well facilitating loans through the new Risk Sharing Finance Facility. "This facility offers the promise to start a new era, not only with much easier access to research funds, but also for managing differently research projects," concluded Mr Potocnik.

For more information on the ESFRI, please visit:
http://cordis.europa.eu/esfri/home.html

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...